-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Edited by Yimaitong, please do not reprint without authorization
.
Gout is an ancient disease.
It used to occur mostly in emperors, generals, ministers and dignitaries, so it is known as "the disease of wealth"
.
However, with the improvement of living standards, the prevalence of hyperuricemia in China has reached 13.
3%, and the number of patients has reached 180 million
.
Moreover, the harm of hyperuricemia is not limited to gout
.
Recently, a study published in the journal ANDROLOGIA showed that patients with hyperuricemia have a 59% increased risk of erectile dysfunction (ED) compared with the general population, and that receiving uric acid-lowering therapy can reduce the risk of ED
.
Hyperuricemia and endothelial dysfunction In humans, serum uric acid can affect endothelial function
.
Endothelial dysfunction caused by hyperuricemia is involved in the pathogenesis of cardiovascular disease, and at the same time, endothelial dysfunction is also the main pathogenesis of ED
.
To explore the relationship between hyperuricemia and ED, and to further analyze the effect of uric acid-lowering therapy on the risk of ED
.
We conducted this systematic review and meta-analysis, including 5 cohort studies and 6 cross-sectional studies related to "hyperuricemia and ED" with a total of 454,510 participants
.
Hyperuricemia or substantially increased risk of ED data showed that patients with hyperuricemia had a 1.
59-fold higher risk of developing ED than patients without hyperuricemia (OR=1.
59)
.
Uric acid-lowering therapy reduces the risk of ED by 27% in hyperuricemic patients (OR=1.
27)
.
After subgroup analysis, except for the subgroup of ">60 years old", there was a significant correlation between hyperuricemia and ED
.
Summary This study suggests that hyperuricemia is an important risk factor for ED, and uric acid-lowering therapy can significantly reduce the risk of ED in patients with hyperuricemia
.
Endothelial dysfunction associated with hyperuricemia may underlie the pathogenesis of ED
.
Yimaitong compiled and compiled from: Wang W, Jing Z, Liu W, Zhu L, Ren H, Hou X.
Hyperuricaemia is an important risk factor of the erectile dysfunction: A systematic review and meta-analysis[J].
ANDROLOGIA.
2022 Feb 7: e14384.
DOI: 10.
1111/and.
14384, PMID:35130578